84
Participants
Start Date
July 1, 2017
Primary Completion Date
January 31, 2020
Study Completion Date
April 30, 2020
Empagliflozin 10mg
"Each patient, after the run-in/wash-out phase, will be randomly assigned in a doubleblind fashion to one of the two treatment sequences according to a randomisation list.~and provided by the sponsor."
Placebo Oral Tablet
"Each patient, after the run-in/wash-out phase, will be randomly assigned in a doubleblind fashion to one of the two treatment sequences according to a randomisation list.~and provided by the sponsor."
Clinical Research Center, Department of Nephrology and Hypertension, University of Erlangen-Nuremberg, Erlangen
University of Erlangen-Nürnberg Medical School
OTHER